Anna Christina Muriel, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 | 2024 | 1557 | 1.530 |
Why?
|
Parenting | 7 | 2024 | 707 | 1.430 |
Why?
|
Parents | 15 | 2024 | 3596 | 1.290 |
Why?
|
Bereavement | 2 | 2019 | 310 | 0.920 |
Why?
|
Neoplasms | 25 | 2024 | 22386 | 0.890 |
Why?
|
Psychology | 2 | 2015 | 356 | 0.890 |
Why?
|
Adrenal Cortex Hormones | 2 | 2024 | 1891 | 0.860 |
Why?
|
Mood Disorders | 2 | 2020 | 1128 | 0.780 |
Why?
|
Standard of Care | 2 | 2015 | 571 | 0.740 |
Why?
|
Parent-Child Relations | 8 | 2019 | 775 | 0.740 |
Why?
|
Stress, Psychological | 12 | 2024 | 4538 | 0.730 |
Why?
|
Methylprednisolone | 1 | 2020 | 387 | 0.650 |
Why?
|
Nausea | 2 | 2018 | 682 | 0.610 |
Why?
|
Medical Staff | 1 | 2018 | 40 | 0.610 |
Why?
|
Siblings | 5 | 2023 | 829 | 0.570 |
Why?
|
Adaptation, Psychological | 7 | 2019 | 2665 | 0.550 |
Why?
|
Antiemetics | 1 | 2018 | 188 | 0.540 |
Why?
|
Interpersonal Relations | 4 | 2018 | 1439 | 0.510 |
Why?
|
Dexamethasone | 1 | 2020 | 1965 | 0.420 |
Why?
|
Survivors | 6 | 2023 | 2381 | 0.380 |
Why?
|
Steroids | 1 | 2016 | 937 | 0.370 |
Why?
|
Child | 35 | 2024 | 80863 | 0.360 |
Why?
|
Medication Adherence | 3 | 2020 | 2190 | 0.330 |
Why?
|
Quality of Life | 11 | 2024 | 13497 | 0.310 |
Why?
|
Pediatrics | 3 | 2018 | 3622 | 0.310 |
Why?
|
Referral and Consultation | 2 | 2018 | 3629 | 0.300 |
Why?
|
Medical Oncology | 4 | 2018 | 2347 | 0.300 |
Why?
|
Depression | 7 | 2024 | 8235 | 0.280 |
Why?
|
Psychometrics | 6 | 2024 | 3072 | 0.260 |
Why?
|
Anxiety Disorders | 3 | 2016 | 2754 | 0.260 |
Why?
|
Psychiatry | 1 | 2018 | 1714 | 0.260 |
Why?
|
Depressive Disorder | 2 | 2016 | 3738 | 0.250 |
Why?
|
Anxiety | 5 | 2024 | 4655 | 0.250 |
Why?
|
Physician-Patient Relations | 3 | 2009 | 3267 | 0.240 |
Why?
|
Emotions | 1 | 2016 | 2773 | 0.240 |
Why?
|
Child, Preschool | 13 | 2024 | 42623 | 0.220 |
Why?
|
Antipsychotic Agents | 1 | 2016 | 3077 | 0.210 |
Why?
|
Patients | 1 | 2009 | 909 | 0.210 |
Why?
|
Adolescent | 24 | 2024 | 89168 | 0.190 |
Why?
|
Attitude to Death | 1 | 2004 | 401 | 0.190 |
Why?
|
Burnout, Professional | 2 | 2021 | 712 | 0.180 |
Why?
|
Social Support | 7 | 2016 | 2195 | 0.180 |
Why?
|
Truth Disclosure | 1 | 2003 | 433 | 0.160 |
Why?
|
Humans | 51 | 2024 | 768451 | 0.160 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13708 | 0.160 |
Why?
|
Family Relations | 1 | 2019 | 318 | 0.140 |
Why?
|
Male | 33 | 2024 | 364781 | 0.140 |
Why?
|
Qualitative Research | 5 | 2019 | 3115 | 0.140 |
Why?
|
Problem Solving | 1 | 2020 | 443 | 0.140 |
Why?
|
Social Work | 1 | 2018 | 158 | 0.140 |
Why?
|
Female | 37 | 2024 | 396943 | 0.140 |
Why?
|
Adolescent Psychiatry | 1 | 2018 | 160 | 0.140 |
Why?
|
Marriage | 1 | 2018 | 352 | 0.130 |
Why?
|
Young Adult | 13 | 2024 | 60045 | 0.130 |
Why?
|
Psychological Tests | 1 | 2018 | 643 | 0.130 |
Why?
|
Disabled Children | 1 | 2018 | 251 | 0.120 |
Why?
|
Adult Children | 1 | 2015 | 104 | 0.120 |
Why?
|
Vomiting | 1 | 2018 | 655 | 0.120 |
Why?
|
Adult | 24 | 2024 | 223542 | 0.120 |
Why?
|
Cross-Sectional Studies | 8 | 2024 | 26351 | 0.120 |
Why?
|
School Health Services | 1 | 2018 | 389 | 0.120 |
Why?
|
Mental Health | 2 | 2023 | 3271 | 0.110 |
Why?
|
Brain Neoplasms | 3 | 2016 | 9182 | 0.110 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2017 | 647 | 0.110 |
Why?
|
Neurofibromatosis 1 | 1 | 2018 | 561 | 0.100 |
Why?
|
Child of Impaired Parents | 2 | 2009 | 463 | 0.100 |
Why?
|
Interprofessional Relations | 1 | 2018 | 997 | 0.100 |
Why?
|
Caregivers | 4 | 2020 | 2302 | 0.100 |
Why?
|
Infant | 5 | 2022 | 36497 | 0.100 |
Why?
|
Latex Hypersensitivity | 1 | 2011 | 14 | 0.090 |
Why?
|
Prognosis | 3 | 2024 | 30028 | 0.090 |
Why?
|
Peer Group | 1 | 2016 | 697 | 0.090 |
Why?
|
Poverty | 2 | 2021 | 2719 | 0.090 |
Why?
|
Perception | 1 | 2016 | 1207 | 0.090 |
Why?
|
Middle Aged | 16 | 2024 | 223418 | 0.090 |
Why?
|
Palliative Care | 1 | 2004 | 3644 | 0.080 |
Why?
|
Food Hypersensitivity | 1 | 2017 | 737 | 0.080 |
Why?
|
Family Health | 2 | 2003 | 1256 | 0.070 |
Why?
|
Drug Monitoring | 1 | 2013 | 964 | 0.070 |
Why?
|
Reproducibility of Results | 6 | 2024 | 20231 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3412 | 0.060 |
Why?
|
Risk Factors | 3 | 2023 | 74915 | 0.060 |
Why?
|
Anecdotes as Topic | 1 | 2004 | 56 | 0.060 |
Why?
|
Formularies as Topic | 1 | 2005 | 94 | 0.060 |
Why?
|
Suicide | 2 | 2013 | 1608 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2013 | 9425 | 0.060 |
Why?
|
Emigrants and Immigrants | 1 | 2009 | 548 | 0.050 |
Why?
|
Grief | 1 | 2005 | 255 | 0.050 |
Why?
|
Spain | 2 | 2017 | 491 | 0.050 |
Why?
|
Suicidal Ideation | 1 | 2013 | 1466 | 0.050 |
Why?
|
Clinical Competence | 1 | 2018 | 4841 | 0.050 |
Why?
|
Health Benefit Plans, Employee | 1 | 2005 | 332 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2009 | 2437 | 0.050 |
Why?
|
Cost Sharing | 1 | 2005 | 409 | 0.050 |
Why?
|
Advance Care Planning | 1 | 2009 | 698 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2012 | 4931 | 0.050 |
Why?
|
Sweden | 1 | 2024 | 1382 | 0.050 |
Why?
|
Fatal Outcome | 1 | 2004 | 1840 | 0.040 |
Why?
|
Professional-Family Relations | 1 | 2004 | 501 | 0.040 |
Why?
|
Students | 1 | 2009 | 1751 | 0.040 |
Why?
|
Terminal Care | 2 | 2009 | 1773 | 0.040 |
Why?
|
Glioma | 1 | 2013 | 3523 | 0.040 |
Why?
|
Guideline Adherence | 1 | 2007 | 2239 | 0.040 |
Why?
|
Guidelines as Topic | 1 | 2004 | 1395 | 0.040 |
Why?
|
Communication | 2 | 2018 | 3910 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2021 | 81834 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2009 | 3484 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2023 | 39430 | 0.030 |
Why?
|
Drug Prescriptions | 1 | 2005 | 1677 | 0.030 |
Why?
|
Prospective Studies | 2 | 2017 | 54914 | 0.030 |
Why?
|
Attitude to Health | 1 | 2003 | 2030 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2018 | 5308 | 0.030 |
Why?
|
Germany | 1 | 2015 | 882 | 0.030 |
Why?
|
Social Class | 1 | 2021 | 2000 | 0.030 |
Why?
|
Family | 1 | 2003 | 3208 | 0.020 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2009 | 4636 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2022 | 26395 | 0.020 |
Why?
|
Health Status | 2 | 2013 | 4096 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2007 | 7451 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2005 | 3742 | 0.020 |
Why?
|
Physicians | 1 | 2007 | 4615 | 0.020 |
Why?
|
United States | 4 | 2018 | 73121 | 0.020 |
Why?
|
Anorexia Nervosa | 1 | 1997 | 1363 | 0.020 |
Why?
|
Bipolar Disorder | 1 | 2005 | 5124 | 0.020 |
Why?
|
Prevalence | 2 | 2021 | 15880 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14766 | 0.020 |
Why?
|
Bottle Feeding | 1 | 1988 | 67 | 0.020 |
Why?
|
Program Evaluation | 1 | 2016 | 2508 | 0.020 |
Why?
|
Haiti | 1 | 2009 | 553 | 0.020 |
Why?
|
Health Personnel | 1 | 2021 | 3384 | 0.020 |
Why?
|
Terminally Ill | 1 | 2009 | 240 | 0.020 |
Why?
|
Mass Screening | 1 | 2022 | 5455 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2003 | 21156 | 0.020 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2005 | 303 | 0.020 |
Why?
|
Professional Role | 1 | 2007 | 316 | 0.010 |
Why?
|
Hospitals | 1 | 2018 | 3906 | 0.010 |
Why?
|
Spirituality | 1 | 2009 | 430 | 0.010 |
Why?
|
Drug Utilization Review | 1 | 2005 | 248 | 0.010 |
Why?
|
Prescription Fees | 1 | 2005 | 153 | 0.010 |
Why?
|
Infant, Low Birth Weight | 1 | 1988 | 875 | 0.010 |
Why?
|
Phobic Disorders | 1 | 2005 | 441 | 0.010 |
Why?
|
Personality Inventory | 1 | 2005 | 1019 | 0.010 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2005 | 348 | 0.010 |
Why?
|
Cohort Studies | 2 | 2017 | 41797 | 0.010 |
Why?
|
Home Care Services | 1 | 2009 | 655 | 0.010 |
Why?
|
Hospice Care | 1 | 2009 | 679 | 0.010 |
Why?
|
Language | 1 | 2011 | 1557 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9687 | 0.010 |
Why?
|
Methylphenidate | 1 | 2005 | 491 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 7134 | 0.010 |
Why?
|
Drugs, Generic | 1 | 2005 | 454 | 0.010 |
Why?
|
Reimbursement, Incentive | 1 | 2005 | 548 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2009 | 2119 | 0.010 |
Why?
|
Managed Care Programs | 1 | 2005 | 941 | 0.010 |
Why?
|
Survival Rate | 1 | 2013 | 12875 | 0.010 |
Why?
|
Drug Approval | 1 | 2005 | 817 | 0.010 |
Why?
|
Drug Costs | 1 | 2005 | 1196 | 0.010 |
Why?
|
Boston | 1 | 2009 | 9361 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 24311 | 0.010 |
Why?
|
Suicide, Attempted | 1 | 2005 | 1409 | 0.010 |
Why?
|
Central Nervous System Stimulants | 1 | 2005 | 1180 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 22293 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2005 | 6035 | 0.010 |
Why?
|
Logistic Models | 1 | 2009 | 13324 | 0.010 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 1997 | 490 | 0.010 |
Why?
|
Fluoxetine | 1 | 1997 | 735 | 0.010 |
Why?
|
Sex Factors | 1 | 2007 | 10647 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2007 | 4049 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2011 | 15965 | 0.010 |
Why?
|
Comorbidity | 1 | 2005 | 10601 | 0.010 |
Why?
|
Age of Onset | 1 | 1997 | 3342 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2005 | 4453 | 0.000 |
Why?
|
Maternal Behavior | 1 | 1988 | 309 | 0.000 |
Why?
|
Energy Intake | 1 | 1988 | 2141 | 0.000 |
Why?
|